Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (241-250 of 504) with videos related to

Pageof 51
Sort By:
Oncotarget|October 3, 2015
Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cellsBing Z Carter, Po Yee Mak, Duncan H Mak, et al.
Molecular Cancer Therapeutics|January 19, 2008
CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cellsLinhua Jin, Yoko Tabe, Sergej Konoplev, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|January 7, 2011
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor ModelXiaoyang Ling, Frank Marini, Marina Konopleva, et al.
Haematologica|September 16, 2017
Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanismsPeter P Ruvolo, Huaxian Ma, Vivian R Ruvolo, et al.
Leukemia & Lymphoma|June 14, 2012
Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemiaSergej Konoplev, C Cameron Yin, Steven M Kornblau, et al.
Cancer Research|March 22, 2003
Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapyAaron D Schimmer, Irene Munk Pedersen, Shinichi Kitada, et al.
Stem Cells (Dayton, Ohio)|June 24, 2010
Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cellsVenkata Lokesh Battula, Kurt William Evans, Brett George Hollier, et al.
Annals of Hematology|August 16, 2012
Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cellsTwee Tsao, Yuexi Shi, Steven Kornblau, et al.
Cancer|October 25, 2011
Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicinFarhad Ravandi, Keyur Patel, Rajyalakshmi Luthra, et al.
Scientific Reports|November 17, 2018
Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabineYoko Tabe, Kaori Saitoh, Haeun Yang, et al.
Pageof 51

Showing results (241-250 of 504) with videos related to

Sort By:
Pageof 51
Oncotarget|October 3, 2015
Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cellsBing Z Carter, Po Yee Mak, Duncan H Mak, et al.
Molecular Cancer Therapeutics|January 19, 2008
CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cellsLinhua Jin, Yoko Tabe, Sergej Konoplev, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|January 7, 2011
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor ModelXiaoyang Ling, Frank Marini, Marina Konopleva, et al.
Haematologica|September 16, 2017
Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanismsPeter P Ruvolo, Huaxian Ma, Vivian R Ruvolo, et al.
Leukemia & Lymphoma|June 14, 2012
Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemiaSergej Konoplev, C Cameron Yin, Steven M Kornblau, et al.
Cancer Research|March 22, 2003
Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapyAaron D Schimmer, Irene Munk Pedersen, Shinichi Kitada, et al.
Stem Cells (Dayton, Ohio)|June 24, 2010
Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cellsVenkata Lokesh Battula, Kurt William Evans, Brett George Hollier, et al.
Annals of Hematology|August 16, 2012
Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cellsTwee Tsao, Yuexi Shi, Steven Kornblau, et al.
Cancer|October 25, 2011
Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicinFarhad Ravandi, Keyur Patel, Rajyalakshmi Luthra, et al.
Scientific Reports|November 17, 2018
Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabineYoko Tabe, Kaori Saitoh, Haeun Yang, et al.
Pageof 51